global investor Ginkgo Bioworks has raised $ 265 m in a round that gives the firm , incubated at and backed by the Y Combinator , a value of $ 1.3bn , according to data from investors . Ginkgo , which uses microbugs to create nutrition and food , is one of the hottest companies in its field , and was valued at $ 450 m in June 2016 . Earlier this year , the company partnered with Bayer to form a new venture that aims to combine nutrition and fertiliser , and raised $ 100 million in September .
Boston biotech Ginkgo Bioworks has raised $265m in a round that gives the firm, incubated at and backed by the Y Combinator, a value of $1.3bn, according to data from Pitchbook. Ginkgo, which uses microbugs to create perfumes and food, is one of the hottest properties in its field, and was valued at $450m in June 2016. Earlier this year, the company partnered with Bayer to form a new venture that aims to optimise farming and fertiliser, and raised $100m in September.